DYNE THERAPEUTICS INC (DYN) Institutional Ownership and Insiders Activity
DYNE THERAPEUTICS INC (DYN) is widely held by institutional investors, with 238 firms reporting positions valued at approximately $4.21B based on SEC Form 13F filings for the quarter ended June 30, 2026.
T. Rowe Price Investment Management, Inc. is the largest disclosed holder, reporting approximately $686.56M in DYN holdings in its latest filing.
Recent insider activity includes 50 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
238
Total Reported Value
$4.21B
Largest Holder
T. Rowe Price Investment Management, Inc.
Largest Position
$686.56M
Insider Transactions (90d)
50
Latest Filing Quarter
Q2 2026
New Institutional Positions
48
Funds Exiting Positions
37
Top Institutional Owners
View all- T. Rowe Price Investment Management, Inc.$686.56M
- Blackrock, Inc.$275.50M
- Fmr Llc$248.91M
- Janus Henderson Group Plc$247.43M
- State Street Corp$165.65M
DYN News
All news- Palo Alto Investors Q2 2026 Portfolio Changes: Major Buys and Minor Sells in Biotech Focus
Aug 22, 2026 · valut.ai
Related DYN Institutional Insights:
- DYN 13F Institutional Holders
- DYN Top Institutional Shareholders
- DYN Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- DYN Insider Trading & SEC Form 4 Activity
- DYN Articles
- Top Institutional Investor Stock Rankings